NCT07042568

Brief Summary

This study aims to evaluate the effect of nursing education provided to women diagnosed with breast cancer undergoing chemotherapy on their quality of life and the severity of oral mucositis (mouth sores). The main questions this study aims to answer are:

  1. 1.Does nursing education aimed at preventing oral mucositis in women diagnosed with breast cancer have an effect on quality of life?
  2. 2.Does nursing education aimed at preventing oral mucositis in women diagnosed with breast cancer have an effect on the severity of oral mucositis? The researchers will evaluate the effect of nursing education on quality of life and oral mucositis severity by randomly assigning one group to receive education and the other group to not receive education.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 29, 2025

Completed
Last Updated

June 29, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

June 17, 2025

Last Update Submit

June 27, 2025

Conditions

Keywords

EducationBreast cancerChemotherapyOral mucositisQuality of lifeNursing

Outcome Measures

Primary Outcomes (1)

  • Comparison of general health, functional and symptom-related quality of life (QLQ-C30), WHO oral toxicity criteria and ADR measurement scores within and between the intervention and control groups

    The European Organisation for Research and Treatment of Cancer QLQ-C30 Version 3.0 Quality of Life Scale consists of a total of 30 questions divided into three subscales: general well-being, functional scale, and symptom scale. In this scale developed by the WHO, stage 0 represents normal oral mucosa, while stage 4 represents the highest severity of oral mucositis. The Oral Assessment Guide (OAG) covers eight areas: voice, swallowing, tongue, lips, oral mucosa, saliva, gums, and teeth/dentures. When calculating the final total oral mucosa score, the scores obtained from these eight areas are added together. The lowest score is 8, and the highest score is 24. An increase in the score indicates an increase in the severity of oral mucositis, while a decrease indicates a decrease in the severity of oral mucositis.

    First day and 21st day

Study Arms (2)

Intervention (Education + Telephone consultation)

EXPERIMENTAL
Behavioral: Nursing education aimed at preventing oral mucositis

Control group

NO INTERVENTION

They continued to receive routine nursing care.

Interventions

The intervention group was trained on the use of the Oral Mucositis Prevention Patient Education Handbook, which was prepared by the researchers based on literature information and expert opinions. Participants in the intervention group received telephone consultations on days 7 and 14. The control group continued to receive routine nursing care. The second interview was completed on day 21, when both the intervention and control group patients returned for their next treatment cycle, using the WHO Oral Toxicity Criteria, ADR, and EORTC QLQ-C30 Version 3.0 Quality of Life Scale.

Intervention (Education + Telephone consultation)

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women diagnosed with breast cancer and undergoing chemotherapy,
  • Aged 18 or older,
  • Volunteering to participate in the study,
  • Able to communicate, read and write in Turkish,
  • With at least 3 weeks of chemotherapy treatment remaining

You may not qualify if:

  • Having a known psychiatric illness that could interfere with the intervention and data collection process,
  • Receiving chemo-radiotherapy,
  • Having cognitive, perceptual, or communication issues that may affect their ability to understand the provided education.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balkan Oncology Hospital affiliated with Trakya University Hospital, Trakya University, Republic of Turkey

Edirne, 22030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast NeoplasmsStomatitis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

June 17, 2025

First Posted

June 29, 2025

Study Start

February 13, 2023

Primary Completion

June 15, 2023

Study Completion

August 15, 2023

Last Updated

June 29, 2025

Record last verified: 2025-06

Locations